RemeGen Co. Ltd. Class A - Enterprise Value

The Enterprise Value as of October 2026 (TTM) for RemeGen Co. Ltd. Class A (688331.SS) is 63.70B

According to RemeGen Co. Ltd. Class A’s latest financial reports and current stock price. The company's current Enterprise Value is 63.70B. This represents a change of 0.30% compared to the average of 63.50B of the last 4 quarters.

RemeGen Co. Ltd. Class A (688331.SS) Historical Enterprise Value (quarterly & annually)

How has 688331.SS Enterprise Value performed in the past?

The mean historical Enterprise Value of RemeGen Co. Ltd. Class A over the last ten years is 22.38B. The current 63.70B Enterprise Value has changed 28.36% with respect to the historical average. Over the past ten years (40 quarters), 688331.SS's Enterprise Value was at its highest in in the March 2026 quarter at 73.01B. The Enterprise Value was at its lowest in in the March 2019 quarter at 0.

RemeGen Co. Ltd. Class A (688331.SS) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of RemeGen Co. Ltd. Class A Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

RemeGen Co. Ltd. Class A (688331.SS) Average Enterprise Value

How has 688331.SS Enterprise Value performed in the past?

The current Enterprise Value of RemeGen Co. Ltd. Class A (688331.SS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

RemeGen Co. Ltd. Class A (688331.SS) Enterprise Value vs. Peers

How is 688331.SS’s Enterprise Value compared to its peers?

RemeGen Co. Ltd. Class A’s Enterprise Value is greater than BeOne Medicines Ltd. Class A (37.26B), greater than Shanghai Junshi Biosciences Co., Ltd. (39.50B), greater than Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (36.85B), greater than Shanghai Allist Pharmaceuticals Co., Ltd. (49.11B), less than Jiangsu Hengrui Medicine Co., Ltd. (263.08B), less than Sichuan Kelun Pharmaceutical Co., Ltd. Class A (64.36B), greater than Suzhou Zelgen Biopharmaceuticals Co., Ltd. (27.88B), greater than Mabwell (Shanghai) Bioscience Co., Ltd. (11.53B), less than Evopoint Biosciences Co. Ltd. (0),

Build a custom stock screener for RemeGen Co. Ltd. Class A (688331.SS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like RemeGen Co. Ltd. Class A using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

RemeGen Co. Ltd. Class A (688331.SS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like RemeGen Co. Ltd. Class A or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.